跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 89,421 条关于
“PTEN/SHP1-deficient cancers”
全部
89,421
临床试验
77,547
药物
1,643
机构
525
资讯
9,706
5个月前
OneMedNet Partners with Onco-Innovations to Accelerate PNKP Inhibitor Development Using AI-Powered Real-World Data
11个月前
Capivasertib Shows Significant Survival Benefit in PTEN-Deficient Metastatic Prostate Cancer
去年
Truqap Plus Abiraterone Shows Promise in PTEN-Deficient Metastatic Prostate Cancer
去年
Truqap plus Abiraterone and ADT Improves rPFS in PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer
去年
Capivasertib Plus Abiraterone Extends Radiographic Progression-Free Survival in PTEN-Deficient mHSPC
6个月前
CAPItello-281 Trial Shows Capivasertib Plus Abiraterone Maintains Quality of Life in PTEN-Deficient Prostate Cancer
2年前
NXP800 Receives FDA Orphan Drug Designation for ARID1a-Deficient Ovarian Cancers
9个月前
Rakovina Therapeutics Presents AI-Discovered CNS-Penetrant ATR/mTOR Dual Inhibitors at Neuro-Oncology Meeting
去年
Dostarlimab Shows Promise in Eliminating Need for Surgery Across Multiple dMMR Cancer Types
3年前
Repare Therapeutics' ATR Inhibitor Camonsertib Shows Promise in DNA Repair-Deficient Cancers
第 1 页，共 971 页
上一页
下一页
